Rose Biomedical Development Corporation
Records under this name other than patents Rose Biomedical Development Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Rose Biomedical Development Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,695,490 | Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities Formerly held Term ended Term ended Oct 28, 2025 · From the USPTO record | Term ended | Term ended Oct 28, 2025 | From the USPTO record |
| US 7,108,706 | Inflatable nasal packing device with two non-elastic, flexible bags oversized relative to nasal cavities Term ended Term ended Oct 27, 2023 · From the USPTO record | Term ended | Term ended Oct 27, 2023 | From the USPTO record |
| US 6,751,743 | Method and apparatus for selecting a first clock and second clock for first and second devices respectively from an up-converted clock and an aligned clock for synchronization Term ended Term ended Oct 27, 2022 · From the USPTO record | Term ended | Term ended Oct 27, 2022 | From the USPTO record |
| US 6,682,497 | Methods and apparatus for treating plantar ulcerations Term ended Term ended Jan 9, 2019 · From the USPTO record | Term ended | Term ended Jan 9, 2019 | From the USPTO record |
| US 6,228,044 | Methods and apparatus for treating plantar ulcerations Term ended Term ended Jan 5, 2019 · From the USPTO record | Term ended | Term ended Jan 5, 2019 | From the USPTO record |
| US 6,500,165 | Active antisepsis device Formerly held Lapsed on the fee record Ended Dec 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2014 | From the USPTO record |
| US 6,254,537 | Fetal outcome predictor and monitoring system Lapsed on the fee record Ended Jul 3, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jul 3, 2009 | From the USPTO record |